Share This Page
Drug Price Trends for NDC 51407-0277
✉ Email this page to a colleague
Average Pharmacy Cost for 51407-0277
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 51407-0277
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| THIOTHIXENE HCL 5MG CAP | Golden State Medical Supply, Inc. | 51407-0277-01 | 100 | 189.52 | 1.89520 | 2023-06-15 - 2028-06-14 | FSS |
| THIOTHIXENE HCL 5MG CAP | Golden State Medical Supply, Inc. | 51407-0277-01 | 100 | 191.38 | 1.91380 | 2023-06-23 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 51407-0277
Introduction
The drug identified by NDC 51407-0277 is a pharmaceutical product with a specified formulation and indication. As a vital component of healthcare, understanding its market dynamics, competitive landscape, and future pricing trends is critical for stakeholders—including manufacturers, healthcare providers, insurers, and investors. This analysis offers a comprehensive review of the current market environment, historical pricing, demand projections, and strategic insights to inform decision-making.
Product Overview
NDC 51407-0277 corresponds to [Insert precise drug information: name, dosage form, strength, manufacturer, and intended indication]. This medication primarily targets [indication, e.g., chronic disease, cancer, infectious disease, etc.], positioning it within [relevant therapeutic class]. Its unique formulation, efficacy profile, and administration route distinguish it within its therapeutic segment.
Note: Precise product details are essential to refine this analysis; consult the FDA NDC Directory for exact specifications if needed.
Current Market Landscape
Market Size & Demand Dynamics
Recent data indicates that [insert recent sales volumes, revenue figures, or prescription counts] for this product’s therapeutic class. The global pharmaceutical market for [drug class/indication] is projected to grow at a CAGR of [X]% over the next [Y] years, driven by increasing disease prevalence, aging populations, and unmet medical needs [1].
Specifically, this drug’s usage is concentrated within [geographies, e.g., North America, Europe, Asia], with North America accounting for approximately [X]% of prescriptions, owing to favorable reimbursement policies and high disease incidence.
Competitive Landscape
The product faces competition from [list key competitors, including biosimilars, generics, or branded alternatives]. While the original brand maintains significant market share, recent entry of [mention any recent biosimilars or generics if applicable] is exerting downward pressure on prices and market share.
Importantly, patent expiration or market exclusivity terms influence competition. For NDC 51407-0277, [identify patent status, patent expiry date, or market exclusivity period] significantly impact market dynamics.
Pricing Trends and Analysis
Historical Price Trends
Data collected from [sources like SSR Health, IQVIA, or public pricing databases] indicates that the average wholesale acquisition cost (AWAC) per unit for this medication has hovered around $[X] in the past [Y] years. The initial launch price was approximately $[X], with fluctuations reflecting market competition, rebate pressures, and payer negotiations.
Price Factors Influencing Future Trends
-
Patent and Exclusivity Status: The expiration of patents typically prompts the entry of biosimilars or generics, causing price reductions. If patent expiry is imminent or has occurred, a conservative price projection should incorporate potential declines of [Z]% in unit costs.
-
Market Penetration & Adoption Rates: Rapid adoption increases revenues; however, reimbursement landscapes, particularly with insurers or government programs like CMS, influence net prices.
-
Regulatory Dynamics: Policy shifts favoring biosimilars or incentivizing cost reductions can accelerate price declines.
-
Manufacturing Costs & Supply Chain: Advances in manufacturing technology and supply chain efficiencies are likely to reduce costs, enabling competitive pricing.
Price Projection Scenarios (2023-2030)
| Year | Optimistic Scenario | Base-Case Scenario | Pessimistic Scenario |
|---|---|---|---|
| 2023 | $[X] - $[Y] | $[X] | $[Y] - $[Z] |
| 2025 | $[X] - $[Y] | $[X] | $[Y] - $[Z] |
| 2030 | $[X] - $[Y] | $[X] | $[Y] - $[Z] |
Assumptions:
- Patent expiry occurs by [date], leading to increased biosimilar competition.
- Regulatory environment remains stable, with no significant pricing reforms.
- Market penetration stabilizes at [X]% of the eligible patient population.
In the base-case scenario, prices are expected to decline approximately [Z]% by 2030 due to biosimilar competition and increased generic options. The optimistic case assumes slower price erosion owing to patent extensions and limited biosimilar uptake, maintaining prices within current levels. Conversely, the pessimistic case factors in aggressive biosimilar entry and payer negotiations, leading to more substantial price drops.
Regulatory Environment Impact
Regulatory policies significantly influence market prices. The push for biosimilar adoption by agencies like the FDA and EMA aims to reduce healthcare costs. The Biosimilar User Fee Act (BIFA) and similar legislation facilitate faster approval processes for biosimilars, which can reduce drug prices by [mean expected reductions: 20-40%] upon entry.
Additionally, reimbursement policies under Medicare and private payers are increasingly favoring cost-effective alternatives, pushing manufacturers to adjust pricing strategies proactively.
Strategic Considerations
-
Patent Litigation and Market Exclusivity: Monitoring patent disputes and exclusivity periods is essential for timing market entry and investment decisions.
-
Biosimilar Development: Engaging with biosimilar producers can provide insights into pricing pressures and market share shifts.
-
Global Expansion: Entering emerging markets can offset domestic price pressures but requires navigating complex regulatory landscapes.
-
Cost Optimization: Innovating manufacturing and supply chain logistics will be crucial for maintaining margins amid declining prices.
Key Takeaways
-
Market Growth: The therapeutic class of NDC 51407-0277 exhibits steady demand growth driven by prevalence rates and treatment guidelines.
-
Competitive Pressures: Biosimilar and generic entries are the primary factors influencing current and future pricing, with significant price erosion anticipated post-patent expiry.
-
Pricing Trajectory: Projected price declines of approximately [X]% between 2023 and 2030** are expected, necessitating strategic planning for profitability.
-
Regulatory Influences: Policies incentivizing biosimilar adoption and cost-reduction efforts will further influence pricing landscapes.
-
Investment Outlook: Stakeholders should consider market lifecycle timelines, patent status, and competitive dynamics to optimize planning and resource allocation.
FAQs
1. What is the current patent status of NDC 51407-0277?
The patent protection for this product is valid until [specific date or year]. Post-expiration, biosimilar competitors are expected to enter the market, exerting downward pressure on prices.
2. How will biosimilar entry affect the price of this drug?
Biosimilar entry typically reduces prices by 20-40%, depending on competition levels, provider acceptance, and payer agreements. Early market entry and favorable reimbursement policies can accelerate price declines.
3. What are the key factors driving demand for this medication?
Increasing prevalence of [indication], evolving treatment guidelines favoring this therapy, and expanding insurance coverage contribute to rising demand.
4. How do regulatory policies shape future pricing?
Regulatory bodies are facilitating faster biosimilar approvals, encouraging price competition, and advocating for cost-effective care, all leading to potential price reductions.
5. What strategies should manufacturers consider amid declining prices?
Investing in innovation, improving manufacturing efficiencies, expanding into emerging markets, and securing strategic patent positions are vital strategies to sustain profitability.
References
- [Insert source: e.g., IQVIA reports, FDA guidance documents, industry whitepapers]
- [Additional relevant data sources or recent market studies]
This market analysis is intended for informational purposes and should be supplemented with proprietary research specific to organizational strategies.
More… ↓
